Caption Management, LLC Syndax Pharmaceuticals Inc Transaction History

Caption Management, LLC

$8.03 Billion
Q2 2025

A detailed history of Caption Management, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Caption Management, LLC holds 488,900 shares of SNDX stock, worth $7.55 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

488,900

Previous 250,000 95.56%

Holding current value

$7.55 Million

Previous $3.07 Million 49.09%

% of portfolio

0.06%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.9 - $14.15 $2.87 Million - $4.56 Million	322,571 Added 177.33%	504,471 $4.73 Million
Q1 2025 May 15, 2025	SELL	$12.29 - $16.38 $402,706 - $536,723	-32,767 Reduced 15.26%	181,900 $2.24 Million
Q4 2024 Feb 14, 2025	BUY	$12.52 - $21.81 $2.43 Million - $4.24 Million	194,341 Added 956.12%	214,667 $2.84 Million
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $364,445 - $504,288	20,326 New	20,326 $391,000
Q3 2023 Nov 14, 2023	SELL	$14.52 - $21.77 $36,270 - $54,381	-2,498 Reduced 21.17%	9,302 $135,000
Q2 2023 Aug 14, 2023	SELL	$19.35 - $22.31 $61,920 - $71,392	-3,200 Reduced 21.33%	11,800 $246,000
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $309,900 - $434,700	15,000 New	15,000 $316,000
Q1 2022 May 13, 2022	SELL	$14.84 - $22.15 $685,993 - $1.02 Million	-46,226 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$15.23 - $22.47 $704,021 - $1.04 Million	46,226 New	46,226 $1.01 Million
Q3 2021 Nov 12, 2021	SELL	$13.87 - $19.8 $272,254 - $388,654	-19,629 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $447,838 - $840,281	-33,371 Reduced 62.96%	19,629 $337,000
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $385,600 - $491,800	20,000 Added 60.61%	53,000 $1.19 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $330,478 - $578,665	21,886 Added 196.92%	33,000 $733,000
Q3 2020 Nov 16, 2020	BUY	$13.39 - $17.48 $142,121 - $185,532	10,614 Added 2122.8%	11,114 $164,000
Q3 2019 Nov 14, 2019	BUY	$7.47 - $10.76 $3,735 - $5,380	500 New	500 $4,000
Q1 2019 May 14, 2019	SELL	$4.26 - $6.86 $360,677 - $580,808	-84,666 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$3.6 - $8.42 $117,597 - $275,047	32,666 Added 62.82%	84,666 $377,000
Q3 2018 Nov 14, 2018	BUY	$6.33 - $8.08 $329,160 - $420,160	52,000 New	52,000 $421,000

Others Institutions Holding SNDX

# of Institutions

247

Shares Held

100M

Call Options Held

1.28M

Put Options Held

1.29M

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $873M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account

Caption Management, LLC Syndax Pharmaceuticals Inc Transaction History